Top compounds associated with response to ANKK1


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib gCSI pan-cancer AAC 0.11 0.06
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.06
mRNA AT7867 CTRPv2 pan-cancer AAC -0.067 0.06
mRNA MP470 GDSC1000 pan-cancer AAC 0.062 0.06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.06
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.1 0.06
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.064 0.07
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.071 0.07
mRNA BMS-708163 GDSC1000 pan-cancer AAC -0.059 0.07
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.07
Download CSV